LARA NAANOUH: Open Payments
NPI 1598244725 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 24 payments from 10 companies in 2025. Trend: 2023 $769 · 2024 $324 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 5 | $101 |
| Astellas Pharma US Inc | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| Hologic Sales and Service, LLC | 1 | $48 |
| Exeltis, USA Inc. | 3 | $46 |
| Gilead Sciences, Inc. | 2 | $37 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: ZURZUVAE, Veozah, Mirena, FLUENT FLUID MANAGEMENT SYSTEM, SLYND, MYFEMBREE, The Cologuard Plus Collection Kit, ABRYSVO.
Industry payments across IN — which companies pay providers there.
